Transition Bio

Please note: The information displayed on this page might be outdated.
Transition Bio: Transition Bio is a microfluidics-driven drug discovery platform company working to establish a one-of-a-kind technology platform using cell imaging and machine learning to revolutionize condensate drug discovery. They harness droplet microfluidic approaches and cellular platforms to characterize condensates with unprecedented scale and precision, resulting in the mapping of condensates and their modulation, in molecular detail. Their proprietary datasets feed into algorithms that they use for target discovery, target validation and drug design.
Sector/Industry:
Biotech Company
Characteristics:
Based in...
US - New England
Listing
Private
Website:
Address:
Cambridge, MA
United States

Company Participants at Fall Private Company Showcase 2022

  • Greg Miller, CEO